文献速递肿瘤 PET/CT神经核医学

SPECT/CT MIBG显像在高危神经母细胞瘤患者随访中至关重要

SPECT/CT MIBG Imaging Is Crucial in the Follow-up of the Patients With High-Risk Neuroblastoma.
PubMed 文献 · Clin Nucl Med · 2018-01-01

该研究回顾性分析了147例高危神经母细胞瘤患者的170次平面I-MIBG显像及SPECT/CT随访扫描,比较平面图像与SPECT/CT的发现。结果显示61%的检查中两者结果一致,39%的检查中SPECT/CT提供了额外信息。作者认为在高危神经母细胞瘤随访中,SPECT/CT可显著改善平面图像解读并影响患者管理。

要点

  • 147例高危神经母细胞瘤患者的170次I-MIBG显像中,61%平面与SPECT/CT结果一致。
  • 39%的检查中SPECT/CT较平面显像提供额外诊断信息。
  • 作者认为SPECT/CT可显著改善平面图像解读并影响患者管理。

核心结论

  • 在高危神经母细胞瘤患者随访中,SPECT/CT可显著改善平面图像解读并影响患者管理。

研究设计与样本

  • 回顾性分析147例已知高危神经母细胞瘤患者的170次平面I-MIBG显像及SPECT/CT随访扫描。
  • 比较平面图像上I-MIBG摄取增高区域与SPECT/CT的发现。

主要发现

  • 61%的检查中,全身平面图像与SPECT/CT图像结果相同。
  • 39%的检查中,SPECT/CT图像提供了额外信息。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Planar whole-body imaging with I-radiolabeled metaiodobenzylguanidine (I-MIBG) is routinely used in the follow-up evaluation of neuroblastoma. In recent years, SPECT with integrated low-dose CT (SPECT/CT) has become more accessible. We investigated how much SPECT/CT can have additional diagnostic value over planar imaging in detection of residual and recurrent neuroblastoma. METHODS: A total of 170 planar I-MIBG imaging scans with SPECT/CT follow-up scans performed in 147 patients with known high-risk neuroblastoma were retrospectively analyzed. Regions of increased I-MIBG uptake on planar images and the findings on SPECT/CT were compared. RESULTS: In 61% of the studies, the whole-body planar images and SPECT/CT images yielded the same result. In 39% of the time, however, SPECT/CT images provided additional information. CONCLUSIONS: In the follow-up of patients with high-risk neuroblastoma, SPECT/CT can significantly improve planar imaging interpretation and impact patient management.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Liu B, Servaes S, Zhuang H, et al. SPECT/CT MIBG Imaging Is Crucial in the Follow-up of the Patients With High-Risk Neuroblastoma. Clin Nucl Med. 2018. PMID: 29401147. doi:10.1097/RLU.0000000000001984

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。